The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

DSE:IBNSINA Revenue

In the fiscal year ending June 30, 2026, The IBN SINA Pharmaceutical Industry had annual revenue of 13.90B BDT with 16.97% growth. The IBN SINA Pharmaceutical Industry had revenue of 3.49B in the quarter ending June 30, 2026, with 13.82% growth. That makes The IBN SINA Pharmaceutical Industry the 21,858th largest company in the world by revenue and 51st in Bangladesh.

• Revenue: 13.90B
• Revenue Growth: +16.97%
• P/S Ratio: 0.68
• Revenue / Employee: 2.53M
• Employees: 5,500
• Market Cap: 9.40B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Bangladesh 12.23B 98.5%
• Export 184.06M 1.5%

Fiscal year ended Jun 30, 2026 See the full DSE:IBNSINA breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	13.90B	2.02B	16.97%
Jun 30, 2025	11.88B	512.67M	4.51%
Jun 30, 2024	11.37B	2.25B	24.61%
Jun 30, 2023	9.13B	645.51M	7.61%
Jun 30, 2022	8.48B	1.10B	14.96%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error